These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28415616)

  • 1. Z-ligustilide restores tamoxifen sensitivity of ERa negative breast cancer cells by reversing MTA1/IFI16/HDACs complex mediated epigenetic repression of ERa.
    Ma H; Li L; Dou G; Wang C; Li J; He H; Wu M; Qi H
    Oncotarget; 2017 Apr; 8(17):29328-29345. PubMed ID: 28415616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitization of tamoxifen-resistant breast cancer cells by Z-ligustilide through inhibiting autophagy and accumulating DNA damages.
    Qi H; Jiang Z; Wang C; Yang Y; Li L; He H; Yu Z
    Oncotarget; 2017 Apr; 8(17):29300-29317. PubMed ID: 28431397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of estrogen receptor α expression in breast cancer cells by metastasis-associated protein 1.
    Kang HJ; Lee MH; Kang HL; Kim SH; Ahn JR; Na H; Na TY; Kim YN; Seong JK; Lee MO
    Cancer Res; 2014 Mar; 74(5):1484-94. PubMed ID: 24413532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Combinatorial Epigenetic Therapy Using Resveratrol and Pterostilbene for Restoring Estrogen Receptor-α (ERα) Expression in ERα-Negative Breast Cancer Cells.
    Kala R; Tollefsbol TO
    PLoS One; 2016; 11(5):e0155057. PubMed ID: 27159275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minireview: The Link Between ERα Corepressors and Histone Deacetylases in Tamoxifen Resistance in Breast Cancer.
    Légaré S; Basik M
    Mol Endocrinol; 2016 Sep; 30(9):965-76. PubMed ID: 27581354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic reactivation of Nrf2 in murine prostate cancer TRAMP C1 cells by natural phytochemicals Z-ligustilide and Radix angelica sinensis via promoter CpG demethylation.
    Su ZY; Khor TO; Shu L; Lee JH; Saw CL; Wu TY; Huang Y; Suh N; Yang CS; Conney AH; Wu Q; Kong AN
    Chem Res Toxicol; 2013 Mar; 26(3):477-85. PubMed ID: 23441843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptotic cell death induced by Z-Ligustilidein human ovarian cancer cells and role of NRF2.
    Lang F; Qu J; Yin H; Li L; Zhi Y; Liu Y; Fang Z; Hao E
    Food Chem Toxicol; 2018 Nov; 121():631-638. PubMed ID: 30243965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinatorial bioactive botanicals re-sensitize tamoxifen treatment in ER-negative breast cancer via epigenetic reactivation of ERα expression.
    Li Y; Meeran SM; Tollefsbol TO
    Sci Rep; 2017 Aug; 7(1):9345. PubMed ID: 28839265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
    Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
    Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of the antiestrogenic cajanin stilbene acid towards breast cancer.
    Fu Y; Kadioglu O; Wiench B; Wei Z; Wang W; Luo M; Yang X; Gu C; Zu Y; Efferth T
    J Nutr Biochem; 2015 Nov; 26(11):1273-82. PubMed ID: 26365581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender matters: estrogen receptor alpha (ERα) and histone deacetylase (HDAC) 1 and 2 control the gender-specific transcriptional regulation of human uridine diphosphate glucuronosyltransferases genes (UGT1A).
    Kalthoff S; Winkler A; Freiberg N; Manns MP; Strassburg CP
    J Hepatol; 2013 Oct; 59(4):797-804. PubMed ID: 23714156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
    Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
    Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Z-Ligustilide Selectively Targets AML by Restoring Nuclear Receptors Nur77 and NOR-1-mediated Apoptosis and Differentiation.
    Wang C; Liu G; Dou G; Yang Y; Chen L; Ma H; Jiang Z; Ma H; Li C; Li L; Jiang M; Lu Q; Li P; Qi H
    Phytomedicine; 2021 Feb; 82():153448. PubMed ID: 33421904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes.
    Sharma D; Saxena NK; Davidson NE; Vertino PM
    Cancer Res; 2006 Jun; 66(12):6370-8. PubMed ID: 16778215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic induction of tissue inhibitor of matrix metalloproteinase-3 by green tea polyphenols in breast cancer cells.
    Deb G; Thakur VS; Limaye AM; Gupta S
    Mol Carcinog; 2015 Jun; 54(6):485-99. PubMed ID: 24481780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Z-Ligustilide Combined with Cisplatin Reduces PLPP1-Mediated Phospholipid Synthesis to Impair Cisplatin Resistance in Lung Cancer.
    Geng P; Zhao J; Li Q; Wang X; Qin W; Wang T; Shi X; Liu X; Chen J; Qiu H; Xu G
    Int J Mol Sci; 2023 Dec; 24(23):. PubMed ID: 38069368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression.
    Raha P; Thomas S; Thurn KT; Park J; Munster PN
    Breast Cancer Res; 2015 Feb; 17(1):26. PubMed ID: 25848915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.
    deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M
    Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligustilide suppresses the biological properties of Danggui Buxue Tang: a Chinese herbal decoction composed of radix astragali and radix angelica sinensis.
    Zheng YZ; Choi RC; Li J; Xie HQ; Cheung AW; Duan R; Guo AJ; Zhu JT; Chen VP; Bi CW; Zhu Y; Lau DD; Dong TT; Lau BW; Tsim KW
    Planta Med; 2010 Mar; 76(5):439-43. PubMed ID: 19847742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.